PDGFRA and systemic sclerosis: Triggering this intracellular loop by specific autoantibodies against PDGFRα might sustain the myofibroblast phenotype conversion and the persistent profibrotic response of SSc fibroblasts, suggesting a causal role in the pathogenesis of scleroderma [44].